| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $17.15B | +5.8% |
| R&D Expense | $102.0M | +4.1% |
| SG&A Expense | $695.0M | -3.1% |
| Operating Income | $1.80B | -3.8% |
| Interest Expense | $275.0M | -7.7% |
| Pre-tax Income | $842.0M | +2.9% |
| Income Tax | $159.0M | -27.1% |
| Net Income | $683.0M | +13.8% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.04B | -20.9% |
| Inventory | $3.05B | +21.4% |
| Current Assets | $6.71B | +13.0% |
| Total Assets | $16.52B | +12.9% |
| Current Liabilities | $5.11B | +5.8% |
| Long-term Debt | $5.79B | +18.7% |
| Total Liabilities | $12.00B | +10.9% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $951.0M | -27.7% |
| Investing Cash Flow | -$1.69B | -21.8% |
| Financing Cash Flow | $472.0M | +581.6% |
| Stockholders' Equity |
| $4.50B |
| +18.6% |